UHSUHSHealthcare · Medical Care Facilities

UHS Stock Forecast: Universal Health Services, Inc. Price Predictions for 2026-2027

Last close, 24 Aug 2026
$176
−0.49% on the day

The 20 Wall Street analysts covering Universal Health Services, Inc. hold a median 12-month price target of $191 — +8.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 66 of 100 as at 22 Aug 2026 — in the upper half.

Market cap
$10.4B
Ticker Nerd rank
66 / 100
Median analyst target
$191
Analysts covering
20
Total return, dividends reinvested
1W
+3.4%
1M
+13.3%
YTD
−18.9%
1Y
−4.5%
From 52W high
−27.5%
From 52W low
+25.0%
$141
$243
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

UHS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Universal Health Services, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
66 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
98
Quality
86
Growth
79
Volatility
77
Issuance
73
Revisions
40
Accruals
35
Momentum
35
Size
15

Value (98): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Momentum (35): The shares have been drifting down relative to others.

Size (15): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

UHS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on UHS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$150$200$250$300Oct 25Jan 26Apr 26Jul 26UHSHigh $290Median $191Low $166

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says20 analysts
7 Buy12 Hold1 Sell
Low $166Median $191High $290

The green dot is the last close — the median target sits +8.3% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 0 moved their price target up and 7 moved it down.

DateFirmActionRatingTarget
20 Aug 2026RBC CapitalReiteratesSector Perform$183
3 Aug 2026RBC CapitalMaintainsSector Perform
3 Aug 2026RBC CapitalMaintainsSector Perform$190$183
30 July 2026Goldman SachsMaintainsNeutral
30 July 2026Goldman SachsMaintainsNeutral$242$190
29 July 2026BairdMaintainsNeutral
29 July 2026BairdMaintainsNeutral$204$166
29 July 2026Cantor FitzgeraldReiteratesNeutral
29 July 2026Cantor FitzgeraldReiteratesNeutral$194
29 July 2026GuggenheimMaintainsBuy$195$189
29 July 2026GuggenheimMaintainsBuy
29 July 2026Morgan StanleyMaintainsEqual-Weight$212$191
29 July 2026Morgan StanleyMaintainsEqual-Weight
28 July 2026BarclaysMaintainsEqual-Weight$179$168
28 July 2026BarclaysMaintainsEqual-Weight
28 July 2026Cantor FitzgeraldReiteratesNeutral$194
28 July 2026Cantor FitzgeraldReiteratesNeutral
20 July 2026GuggenheimMaintainsBuy
20 July 2026GuggenheimMaintainsBuy$211$195
13 July 2026Wells FargoMaintainsEqual-Weight

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. UHS appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

UHS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−3.3%
Analysts raising
1
Analysts cutting
12
Fundamentals

Universal Health Services, Inc. (UHS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
7.2×

Cheaper than 63% of US stocks

Price / sales
0.6×

Cheaper than 81% of US stocks

Price / book
1.4×

Cheaper than 60% of US stocks

EV / EBITDA
5.8×

Cheaper than 52% of US stocks

Growth & margins
Revenue growth (YoY)
8.3%

Higher than 47% of US stocks

Earnings growth (YoY)
1.5%

Higher than 37% of US stocks

Gross margin
90.9%

Higher than 97% of US stocks

Operating margin
11.1%

Higher than 66% of US stocks

Net margin
8.4%

Higher than 67% of US stocks

Returns & dividend
Return on equity
20.9%

Higher than 82% of US stocks

Return on assets
8.3%

Higher than 89% of US stocks

Dividend yield
0.5%

Higher than 9% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

UHS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
UHSUniversal Health Services, Inc.$10.4B
66
ENSGThe Ensign Group, Inc.$10.4B
67
DVADaVita, Inc.$11.6B
90
EHCEncompass Health Corp.$11.9B
81
CHEChemed Corp.$7.3B
89
PACSPACS Group, Inc.$6.9B
93
LFSTLifestance Health Group, Inc.$4.8B
96

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Universal Health Services, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest UHS news & analysis

Universal Health Shares Drop 21% YTD: Should You Buy Now?

Zacks Investment Research · 20 Aug 2026negative

Universal Health Services shares have fallen 21% year-to-date, lowering its valuation. However, weaker patient volumes, Affordable Care Act pressure, and reduced growth forecasts keep risks elevated, according to Zacks Investment Research.

Why it matters — UHS watchers would care because the stock's decline reflects ongoing operational headwinds that could affect the company's near-term performance and outlook.

UHS Adds Talkspace to Accelerate Virtual Behavioral Health Growth

Zacks Investment Research · 18 Aug 2026positive

Universal Health Services announced an $835 million acquisition of Talkspace to expand its virtual behavioral health offerings, adding approximately 6,000 providers and new growth opportunities.

Why it matters — The acquisition broadens UHS's virtual behavioral health footprint and provider network, potentially strengthening its position in a growing care segment.

Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc.

PRNewsWire · 17 Aug 2026positive

Universal Health Services, Inc. announced the successful completion of its acquisition of Talkspace, Inc., combining one of the nation's largest healthcare services providers with a leading virtual behavioral health platform to create what it describes as the nation's first full continuum of behavioral healthcare services.

Why it matters — UHS watchers would care because the completed deal expands the company's behavioral health offering into virtual care, extending its services across every stage of the mental health journey.

UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Haeggquist & Eck, LLP Investigates Universal Health Services' Directors and Officers for Breach of Fiduciary Duties – UHS

Business Wire · 7 Aug 2026negative

Haeggquist & Eck, LLP has announced an investor alert and is investigating Universal Health Services' directors and officers regarding potential breach of fiduciary duties. The law firm's investigation relates to the company and its leadership, as announced via Business Wire.

Why it matters — A law firm investigation into breach of fiduciary duties by UHS directors and officers signals potential legal and governance concerns for shareholders and those following the company.

Implied Volatility Surging for Universal Health Stock Options

Zacks Investment Research · 3 Aug 2026neutral

Zacks Investment Research reports that implied volatility is surging for Universal Health Services (UHS) stock options, drawing attention to movements in the options market lately. The report suggests investors should closely monitor UHS stock based on these options-market changes.

Why it matters — A rise in implied volatility in UHS options indicates growing market expectations for price movement, which is relevant to those tracking investor sentiment around the stock.

FAQ

Frequently asked questions about UHS stock

What is the UHS stock price forecast for 2026-2027?

The 20 Wall Street analysts covering Universal Health Services, Inc. have a median 12-month price target of $191, with estimates ranging from $166 to $290. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is UHS stock a buy right now?

Of the 20 analysts covering Universal Health Services, Inc., 7 rate it a Buy, 12 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Universal Health Services, Inc. 66 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank UHS?

As at 22 Aug 2026, Universal Health Services, Inc. ranks 66 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (98 of 100).

Will UHS stock go up?

No one can know that. What the data says: the median 12-month target from 20 analysts implies +8.3% from the last close, and Ticker Nerd's factor model ranks Universal Health Services, Inc. 66 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the UHS stock forecast for 2030?

No analyst covering Universal Health Services, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for UHS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $166 to $290 over the next 12 months.

How has UHS stock performed over the past year?

Universal Health Services, Inc. returned -4.5% over the 12 months to 24 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Universal Health Services, Inc. do?

Universal Health Services, Inc. is a healthcare services company that owns and operates a broad network of facilities across the United States.

What is the latest news on UHS?

The most recent item we track (Zacks Investment Research, 20 Aug 2026): "Universal Health Shares Drop 21% YTD: Should You Buy Now?". Universal Health Services shares have fallen 21% year-to-date, lowering its valuation. However, weaker patient volumes, Affordable Care Act pressure, and reduced growth forecasts keep risks elevated, according to Zacks Investment Research.

Company

About Universal Health Services, Inc.

Universal Health Services, Inc. is a healthcare services company that owns and operates a broad network of facilities across the United States. The company focuses on two primary segments: Acute Care Hospital Services and Behavioral Health Services. Its acute care operations include general hospitals, surgical hospitals, freestanding emergency departments, and ambulatory surgery and oncology centers, providing medical, surgical, and emergency care to a wide range of patients. The behavioral health segment delivers inpatient and outpatient services for mental health conditions, substance use disorders, and other behavioral health needs, serving children, adolescents, adults, and seniors. Through these segments, Universal Health Services plays a significant role in the medical care facilities industry, supporting both community-based and specialized care. Headquartered in King of Prussia, Pennsylvania, the company is positioned as a major integrated provider in the U.S. healthcare system, offering essential services that span acute medical treatment, complex behavioral healthcare, and related outpatient services.

CEO Mr. Marc D. Miller · 102,000 employees · United States · https://uhs.com